Vault-13

Cormorant Asset Management, LP

BOSTON, MA · CIK 1583977 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2014 · limited partnership

As an employer

$1.3bn reported value -1.0% vs Q1 2022
79positions
46.6%in top 10
8 new 15 added 15 reduced 6 sold out vs Q1 2022

Options: 1 call positions ($33.4m notional), 0 put positions (— notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TURNING POINT THERAPEUTICS I COM COM 2,484,220 $186.9m14.50% 14.50% ReducedShares held: Q3 2021 2.8m, Q4 2021 3.0m, Q1 2022 3.7m, Q2 2022 2.5m -1.2m -1,215,780 -32.9%
2 DESIGN THERAPEUTICS INC COM DSGN DSGN 5,500,000 $77.0m5.97% 5.97% AddedShares held: Q3 2021 5.4m, Q4 2021 5.4m, Q1 2022 5.2m, Q2 2022 5.5m +343.0k +343,006 6.7%
3 ERASCA INC COM ERAS ERAS 10,505,554 $58.5m4.54% 4.54% UnchangedShares held: Q3 2021 10.5m, Q4 2021 10.5m, Q1 2022 10.5m, Q2 2022 10.5m
4 PROMETHEUS BIOSCIENCES INC COM COM 2,029,158 $57.3m4.44% 4.44% AddedShares held: Q3 2021 1.8m, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 2.0m +205.7k +205,714 11.3%
5 APELLIS PHARMACEUTICALS INC COM APLS APLS 950,000 $43.0m3.33% 3.33% ReducedShares held: Q3 2021 925.0k, Q4 2021 625.0k, Q1 2022 1.1m, Q2 2022 950.0k -175.0k -175,000 -15.6%
6 REVOLUTION MEDICINES INC COM RVMD RVMD 1,995,066 $38.9m3.02% 3.02% UnchangedShares held: Q3 2021 3.1m, Q4 2021 2.4m, Q1 2022 2.0m, Q2 2022 2.0m
7 BIOMEA FUSION INC COM BMEA BMEA 3,170,872 $38.0m2.95% 2.95% UnchangedShares held: Q3 2021 3.2m, Q4 2021 3.2m, Q1 2022 3.2m, Q2 2022 3.2m
8 CHEMOCENTRYX INC COM CCXI CCXI 1,425,000 $35.3m2.74% 2.74% AddedShares held: Q3 2021 0, Q4 2021 400.0k, Q1 2022 865.0k, Q2 2022 1.4m +560.0k +560,000 64.7%
9 ALTIMMUNE INC COM NEW ALT ALT 3,000,000 $35.1m2.72% 2.72% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 3.0m
10 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 6,065,001 $30.9m2.40% 2.40% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 6.1m
11 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 3,850,000 $30.6m2.38% 2.38% ReducedShares held: Q3 2021 3.4m, Q4 2021 3.6m, Q1 2022 4.7m, Q2 2022 3.9m -832.9k -832,874 -17.8%
12 AVIDITY BIOSCIENCES INC COM RNA RNA 2,012,115 $29.2m2.27% 2.27% UnchangedShares held: Q3 2021 2.2m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.0m
13 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 2,993,717 $28.9m2.25% 2.25% ReducedShares held: Q3 2021 3.1m, Q4 2021 3.0m, Q1 2022 3.0m, Q2 2022 3.0m -8.5k -8,482 -0.3%
14 ARCELLX INC COMMON STOCK ACLX ACLX 1,525,000 $27.6m2.14% 2.14% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.5m
15 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,875,000 $27.4m2.12% 2.12% AddedShares held: Q3 2021 1.4m, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.9m +499.0k +499,018 36.3%
16 AEROVATE THERAPEUTICS INC COM COM 1,730,691 $27.1m2.10% 2.10% ReducedShares held: Q3 2021 2.0m, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 1.7m -100.0k -100,000 -5.5%
17 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 184,894 $26.9m2.09% 2.09% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 80.0k, Q2 2022 184.9k +104.9k +104,894 131.1%
18 ADICET BIO INC COM COM 1,800,000 $26.3m2.04% 2.04% AddedShares held: Q3 2021 0, Q4 2021 750.0k, Q1 2022 750.0k, Q2 2022 1.8m +1.1m +1,050,000 140.0%
19 PHARVARIS N V COM PHVS PHVS 1,145,953 $25.3m1.96% 1.96% AddedShares held: Q3 2021 689.7k, Q4 2021 689.7k, Q1 2022 684.9k, Q2 2022 1.1m +461.1k +461,065 67.3%
20 FORMA THERAPEUTICS HLDGS INC SHS SHS 3,172,204 $21.9m1.70% 1.70% ReducedShares held: Q3 2021 4.7m, Q4 2021 4.6m, Q1 2022 4.1m, Q2 2022 3.2m -896.1k -896,147 -22.0%
21 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 267,500 $21.3m1.66% 1.66% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 100.0k, Q2 2022 267.5k +167.5k +167,500 167.5%
22 TANGO THERAPEUTICS INC COM TNGX TNGX 4,507,843 $20.4m1.58% 1.58% ReducedShares held: Q3 2021 3.9m, Q4 2021 4.9m, Q1 2022 4.9m, Q2 2022 4.5m -391.3k -391,342 -8.0%
23 MIRATI THERAPEUTICS INC COM MRTX MRTX 300,000 $20.1m1.56% 1.56% AddedShares held: Q3 2021 120.0k, Q4 2021 75.0k, Q1 2022 50.0k, Q2 2022 300.0k +250.0k +250,000 500.0%
24 AXONICS INC COM AXNX AXNX 322,240 $18.3m1.42% 1.42% UnchangedShares held: Q3 2021 322.2k, Q4 2021 322.2k, Q1 2022 322.2k, Q2 2022 322.2k
25 KARUNA THERAPEUTICS INC COM COM 125,000 $15.8m1.23% 1.23% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 150.0k, Q2 2022 125.0k -25.0k -25,000 -16.7%
26 CYTOKINETICS INC COM NEW CYTK CYTK 400,000 $15.7m1.22% 1.22% UnchangedShares held: Q3 2021 1.0m, Q4 2021 700.0k, Q1 2022 400.0k, Q2 2022 400.0k
27 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 275,000 $15.7m1.22% 1.22% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 150.0k, Q2 2022 275.0k +125.0k +125,000 83.3%
28 VECTIVBIO HLDG AG ORD SHS ORD SHS 2,840,389 $15.3m1.19% 1.19% AddedShares held: Q3 2021 2.2m, Q4 2021 2.2m, Q1 2022 2.1m, Q2 2022 2.8m +761.9k +761,904 36.7%
29 GREENLIGHT BIOSCIENCS HLDS P COMMON STOCK COMMON STOCK 6,960,540 $15.2m1.18% 1.18% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 6.7m, Q2 2022 7.0m +250.0k +250,000 3.7%
30 STOKE THERAPEUTICS INC COM STOK STOK 1,087,807 $14.4m1.11% 1.11% UnchangedShares held: Q3 2021 1.3m, Q4 2021 1.2m, Q1 2022 1.1m, Q2 2022 1.1m
31 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 2,927,273 $14.3m1.11% 1.11% AddedShares held: Q3 2021 1.7m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.9m +437.4k +437,379 17.6%
32 BRIDGEBIO PHARMA INC COM BBIO BBIO 1,469,179 $13.3m1.03% 1.03% ReducedShares held: Q3 2021 1.8m, Q4 2021 1.7m, Q1 2022 1.6m, Q2 2022 1.5m -99.7k -99,730 -6.4%
33 RAIN ONCOLOGY INC COM COM 2,326,660 $12.9m1.00% 1.00% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
34 IMMUNEERING CORP CLASS A COM IMRX IMRX 2,286,181 $12.4m0.96% 0.96% ReducedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m -16.4k -16,445 -0.7%
35 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 868,550 $12.0m0.93% 0.93% UnchangedShares held: Q3 2021 968.5k, Q4 2021 868.5k, Q1 2022 868.5k, Q2 2022 868.5k
36 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 475,000 $11.7m0.91% 0.91% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 475.0k
37 ATEA PHARMACEUTICALS INC COM AVIR AVIR 1,547,181 $11.0m0.85% 0.85% UnchangedShares held: Q3 2021 4.9m, Q4 2021 1.7m, Q1 2022 1.5m, Q2 2022 1.5m
38 VERVE THERAPEUTICS INC COM COM 700,710 $10.7m0.83% 0.83% UnchangedShares held: Q3 2021 709.2k, Q4 2021 1.1m, Q1 2022 700.7k, Q2 2022 700.7k
39 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 877,500 $10.2m0.79% 0.79% ReducedShares held: Q3 2021 342.6k, Q4 2021 300.0k, Q1 2022 1.0m, Q2 2022 877.5k -122.5k -122,500 -12.2%
40 KEZAR LIFE SCIENCES INC COM COM 1,200,000 $9.9m0.77% 0.77% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.2m
41 VENTYX BIOSCIENCES INC COM VTYX VTYX 780,643 $9.5m0.74% 0.74% ReducedShares held: Q3 2021 0, Q4 2021 785.3k, Q1 2022 785.3k, Q2 2022 780.6k -4.7k -4,660 -0.6%
42 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 2,082,000 $8.5m0.66% 0.66% UnchangedShares held: Q3 2021 3.1m, Q4 2021 2.2m, Q1 2022 2.1m, Q2 2022 2.1m
43 AXSOME THERAPEUTICS INC COM AXSM AXSM 205,000 $7.9m0.61% 0.61% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 205.0k
44 LONGBOARD PHARMACEUTICALS IN COM COM 2,273,221 $7.0m0.54% 0.54% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
45 COGENT BIOSCIENCES INC COM COGT COGT 750,000 $6.8m0.52% 0.52% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 750.0k
46 AMBRX BIOPHARMA INC SPONSORED ADS SPONSORED ADS 2,486,386 $6.6m0.51% 0.51% UnchangedShares held: Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.5m
47 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 608,123 $6.1m0.47% 0.47% UnchangedShares held: Q3 2021 608.1k, Q4 2021 608.1k, Q1 2022 608.1k, Q2 2022 608.1k
48 BIOATLA INC COM BCAB BCAB 2,038,215 $5.8m0.45% 0.45% UnchangedShares held: Q3 2021 1.8m, Q4 2021 1.7m, Q1 2022 2.0m, Q2 2022 2.0m
49 ALX ONCOLOGY HLDGS INC COM ALXO ALXO 712,079 $5.8m0.45% 0.45% UnchangedShares held: Q3 2021 1.0m, Q4 2021 762.1k, Q1 2022 712.1k, Q2 2022 712.1k
50 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 200,000 $5.4m0.42% 0.42% NewShares held: Q3 2021 0, Q4 2021 100.0k, Q1 2022 0, Q2 2022 200.0k
51 TYRA BIOSCIENCES INC COM TYRA TYRA 743,988 $5.3m0.41% 0.41% ReducedShares held: Q3 2021 1.1m, Q4 2021 839.9k, Q1 2022 757.4k, Q2 2022 744.0k -13.4k -13,444 -1.8%
52 TALARIS THERAPEUTICS INC COM COM 1,174,723 $5.3m0.41% 0.41% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
53 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 50,000 $4.6m0.36% 0.36% UnchangedShares held: Q3 2021 170.0k, Q4 2021 50.0k, Q1 2022 50.0k, Q2 2022 50.0k
54 PLIANT THERAPEUTICS INC COM PLRX PLRX 482,413 $3.9m0.30% 0.30% UnchangedShares held: Q3 2021 482.4k, Q4 2021 482.4k, Q1 2022 482.4k, Q2 2022 482.4k
55 AKERO THERAPEUTICS INC COM AKRO AKRO 403,787 $3.8m0.30% 0.30% UnchangedShares held: Q3 2021 600.0k, Q4 2021 403.8k, Q1 2022 403.8k, Q2 2022 403.8k
56 ICOSAVAX INC COM COM 651,393 $3.7m0.29% 0.29% AddedShares held: Q3 2021 426.4k, Q4 2021 426.4k, Q1 2022 426.4k, Q2 2022 651.4k +225.0k +225,000 52.8%
57 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 1,305,095 $3.2m0.25% 0.25% UnchangedShares held: Q3 2021 1.3m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.3m
58 ELEVATION ONCOLOGY INC COM COM 1,983,168 $2.8m0.22% 0.22% AddedShares held: Q3 2021 2.0m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.0m +3 +3 0.0%
59 KEROS THERAPEUTICS INC COM KROS KROS 100,000 $2.8m0.21% 0.21% UnchangedShares held: Q3 2021 0, Q4 2021 150.0k, Q1 2022 100.0k, Q2 2022 100.0k
60 Y-MABS THERAPEUTICS INC COM YMAB YMAB 150,000 $2.3m0.18% 0.18% UnchangedShares held: Q3 2021 500.0k, Q4 2021 300.0k, Q1 2022 150.0k, Q2 2022 150.0k
61 AKOUOS INC COM COM 394,500 $1.9m0.14% 0.14% UnchangedShares held: Q3 2021 394.5k, Q4 2021 394.5k, Q1 2022 394.5k, Q2 2022 394.5k
62 GALECTO INC COM GLTO GLTO 1,020,238 $1.8m0.14% 0.14% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
63 GOSSAMER BIO INC COM GOSS GOSS 198,382 $1.7m0.13% 0.13% UnchangedShares held: Q3 2021 198.4k, Q4 2021 198.4k, Q1 2022 198.4k, Q2 2022 198.4k
64 PYXIS ONCOLOGY INC COMMON STOCK PYXS PYXS 668,854 $1.6m0.12% 0.12% UnchangedShares held: Q3 2021 0, Q4 2021 668.9k, Q1 2022 668.9k, Q2 2022 668.9k
65 VIGIL NEUROSCIENCE INC COM VIGL VIGL 616,786 $1.6m0.12% 0.12% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 616.8k, Q2 2022 616.8k
66 CABALETTA BIO INC COM CABA CABA 1,154,424 $1.2m0.09% 0.09% UnchangedShares held: Q3 2021 1.6m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
67 MEIRAGTX HLDGS PLC COM MGTX MGTX 150,000 $1.1m0.09% 0.09% UnchangedShares held: Q3 2021 0, Q4 2021 150.0k, Q1 2022 150.0k, Q2 2022 150.0k
68 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 392,167 $1.1m0.09% 0.09% UnchangedShares held: Q3 2021 392.2k, Q4 2021 392.2k, Q1 2022 392.2k, Q2 2022 392.2k
69 CHEMOMAB THERAPEUTICS LTD SPONSORED ADS SPONSORED ADS 288,168 $1.1m0.08% 0.08% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 288.2k, Q2 2022 288.2k
70 HARPOON THERAPEUTICS INC COM COM 540,600 $1.0m0.08% 0.08% UnchangedShares held: Q3 2021 540.6k, Q4 2021 540.6k, Q1 2022 540.6k, Q2 2022 540.6k
71 ANAPTYSBIO INC COM ANAB ANAB 50,000 $1.0m0.08% 0.08% UnchangedShares held: Q3 2021 385.1k, Q4 2021 100.0k, Q1 2022 50.0k, Q2 2022 50.0k
72 RENOVACOR INC COM COM 500,000 $1.0m0.08% 0.08% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
73 GELESIS HLDGS INC COM GLSHQ GLSHQ 626,108 $970.0k0.08% 0.08% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 626.1k, Q2 2022 626.1k
74 ASTRIA THERAPEUTICS INC COM CATB CATB 300,000 $900.0k0.07% 0.07% UnchangedShares held: Q3 2021 552.9k, Q4 2021 552.9k, Q1 2022 300.0k, Q2 2022 300.0k
75 ATRECA INC CL A COM BCEL BCEL 319,057 $571.0k0.04% 0.04% ReducedShares held: Q3 2021 273.5k, Q4 2021 273.5k, Q1 2022 800.0k, Q2 2022 319.1k -480.9k -480,943 -60.1%
76 GRAPHITE BIO INC COM GRPH GRPH 199,547 $549.0k0.04% 0.04% ReducedShares held: Q3 2021 203.2k, Q4 2021 203.2k, Q1 2022 203.2k, Q2 2022 199.5k -3.6k -3,606 -1.8%
77 IMV INC COM COM 234,374 $155.0k0.01% 0.01% UnchangedShares held: Q3 2021 234.4k, Q4 2021 234.4k, Q1 2022 234.4k, Q2 2022 234.4k
78 ORCHARD THERAPEUTICS PLC ADS ORTX ORTX 256,649 $150.0k0.01% 0.01% UnchangedShares held: Q3 2021 256.6k, Q4 2021 256.6k, Q1 2022 256.6k, Q2 2022 256.6k
79 X4 PHARMACEUTICALS INC COM COM 103,980 $100.0k0.01% 0.01% UnchangedShares held: Q3 2021 104.0k, Q4 2021 104.0k, Q1 2022 104.0k, Q2 2022 104.0k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
HELIX ACQUISITION CORP MLTX MLTX 3,280,000 $33.3m3.3m shares
IGM BIOSCIENCES INC IGMS IGMS 402,200 $10.8m402.2k shares
PRAXIS PRECISION MEDICINES I 752,406 $7.7m752.4k shares
BEAM THERAPEUTICS INC BEAM BEAM 90,045 $5.2m90.0k shares
ITEOS THERAPEUTICS INC ITOS ITOS 100,000 $3.2m100.0k shares
PRECISION BIOSCIENCES INC 346,524 $1.1m346.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Call XBICall 450,000 $33.4m450.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
CORBUS PHARMACEUTICALS HLDGS CRBP · 13G · filed 2025-12-15 CRBP 13.4%≈ $22.0m +0.5 pts 13G 2025-12-15
IBIO INC IBIO · 13G · filed 2026-08-14 IBIO 10.0%≈ $9.0m no change 13G 2026-08-14
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 IRLA 10.0%≈ $2.0m new 13G 2026-08-14
BRIGHT MINDS BIOSCIENCES INC DRUG · 13G · filed 2026-08-14 DRUG 9.2%≈ $32.0m -0.5 pts 13G 2026-08-14
EYEPOINT PHARMACEUTICALS INC EYPT · 13G · filed 2026-08-14 EYPT 8.3%≈ $100.1m -1.6 pts 13G 2026-08-14
CARGO THERAPEUTICS INC 13G · filed 2025-05-15 7.3% new 13G 2025-05-15
ADLAI NORTYE LTD ANL · 13G · filed 2026-08-14 ANL 6.8% +1.6 pts 13G 2026-08-14
CABALETTA BIO INC CABA · 13G · filed 2026-08-14 CABA 6.0%≈ $31.1m -3.1 pts 13G 2026-08-14
RAPPORT THERAPEUTICS INC RAPP · 13G · filed 2026-08-14 RAPP 5.6%≈ $110.7m -0.6 pts 13G 2026-08-14
BIOAGE LABS INC BIOA · 13G · filed 2026-08-14 BIOA 5.4%≈ $58.6m -1.1 pts 13G 2026-08-14
AGOMAB THERAPEUTICS NV AGMB · 13G · filed 2026-05-15 AGMB 5.0% new 13G 2026-05-15